Encouraging data from Johnson & Johnson on Ebola vaccine
Johnson & Johnson says data published in The Lancet on its Ebola vaccine regimen shows it has a robust and durable immune response in adults and children.
Archives for September 14, 2021
BMS joins $75m funding round for French biotech developing pipeline of stem cell-derived cell therapies
French innovator, TreeFrog Therapeutics, which is focused on developing affordable stem cell-derived cell therapies, has just closed a US$75m (€64M) Series B financing round, bringing its total funding to date to US$83m (€70M).
CureVac terminates COVID-19 vaccine manufacturing contracts with Wacker and Celonic
CureVac is streamlining its external European manufacturing network for its mRNA product pipeline; having reassessed demand for its first-generation COVID-19 vaccine candidate.